Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases
Patent No. EP3783027 (titled "Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases") was filed by OSE Immunotherapeutics on Oct 21, 2015. The application was issued on Dec 3, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3783027
- Application Number
- EP20177260A
- Filing Date
- Oct 21, 2015
- Status
- Granted And Under Opposition
- Oct 31, 2025
- Publication Date
- Dec 3, 2025
- External Links
- Slate, Register , Google Patents